Technical Report Health Policy Medical Education Nursing
Emergency department revisits after telemedicine follow-up in patients on haemodialysis: A multicentre observational study

Emergency department revisits after telemedicine follow-up in patients on haemodialysis: A multicentre observational study

Authors

Lucas Tanaka

Lucas Tanaka

Hamad Medical Corporation, Greenland

Hana Yilmaz

Hana Yilmaz

American University of Beirut Medical Center, Gabon

Corresponding

Published

May 7, 2026

Paper ID

PAP-000264

Status

Published

DOI

10.65712/tmj.test000522

Emergency department revisits after telemedicine follow-up in patients on haemodialysis: A multicentre observational study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on telemedicine follow-up. Methods: Missing data were handled with multiple imputation. Results: Serious adverse events were rare and similar between groups. 3754 participants were included (median age 32 years). Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

emergency department revisits remains a leading cause of avoidable harm among patients on haemodialysis. Earlier studies of telemedicine follow-up were small or single-centre.

Guidelines make only a weak recommendation on telemedicine follow-up. emergency department revisits remains a leading cause of avoidable harm among patients on haemodialysis. Earlier studies of telemedicine follow-up were small or single-centre.

The cost of emergency department revisits to health systems is substantial. Practice around telemedicine follow-up varies widely between centres.

Guidelines make only a weak recommendation on telemedicine follow-up. emergency department revisits remains a leading cause of avoidable harm among patients on haemodialysis.

Discussion

These findings suggest that telemedicine follow-up is associated with better emergency department revisits in patients on haemodialysis. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. Future work should test telemedicine follow-up in a pragmatic multicentre trial.

Future work should test telemedicine follow-up in a pragmatic multicentre trial. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. These findings suggest that telemedicine follow-up is associated with better emergency department revisits in patients on haemodialysis. Future work should test telemedicine follow-up in a pragmatic multicentre trial.

Conclusions

Telemedicine follow-up may be offered for patients on haemodialysis to improve emergency department revisits.

References

1. Rahman O, Mueller O, et al. Point-of-care ultrasound and length of stay. N Engl J Med. 2022;238(2):93-1674.

2. Rahman Y, Rossi N, et al. Continuous glucose monitoring and chronic pain scores. N Engl J Med. 2013;307(7):93-1403.

3. Ahmed K, Moreau X, et al. Delayed cord clamping and 30-day readmission. Lancet. 2021;206(5):532-1085.

4. Silva Y, Rahman E, et al. Tranexamic acid and length of stay. Crit Care Med. 2019;262(2):249-1291.

5. Silva T, Novak D, et al. Delayed cord clamping and glycaemic control. BMC Med. 2013;347(6):143-1771.

6. Ahmed H, Ibrahim W, et al. Pharmacist-led medication review and chronic pain scores. Diabetes Care. 2011;62(12):229-1079.

7. Nakamura E, Rossi V, et al. Frailty screening and acute kidney injury. Lancet. 2022;135(4):838-1096.

Appendices

The statistical analysis plan is in the online supplement.

Materials and Methods

We conducted a multicentre observational study across 5 centres between 2015 and 2024. We conducted a multicentre observational study across 12 centres between 2020 and 2024. Missing data were handled with multiple imputation.

Eligible participants were patients on haemodialysis. Missing data were handled with multiple imputation. We conducted a multicentre observational study across 7 centres between 2015 and 2023.

Missing data were handled with multiple imputation. Eligible participants were patients on haemodialysis. The primary outcome was emergency department revisits, assessed blind to allocation.

Results

Serious adverse events were rare and similar between groups. 2680 participants were included (median age 52 years). The adjusted odds ratio was 0.60 (95% CI 0.36 to 0.95). The adjusted odds ratio was 0.64 (95% CI 0.27 to 0.75).

Serious adverse events were rare and similar between groups. 938 participants were included (median age 75 years). emergency department revisits occurred in 19% of the intervention group versus 35% of controls. The adjusted odds ratio was 0.64 (95% CI 0.49 to 0.83).

The adjusted odds ratio was 0.44 (95% CI 0.25 to 0.63). Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. emergency department revisits occurred in 20% of the intervention group versus 12% of controls.

GroupnEventsRate %OR95% CI
Age < 6575510936.80.810.48–1.21
Intervention3362010.50.760.23–1.40
Age ≥ 657986418.20.710.60–1.29
Age ≥ 654843039.00.730.44–1.39
Age < 651814732.80.620.41–1.27
Age ≥ 65971533.70.750.33–1.36
Centre A4098310.30.870.41–1.3
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of emergency department revisits
Shown for patients on haemodialysis; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in emergency department revisits
Shown for patients on haemodialysis; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.83 (95% CI 0.27 to 0.71). The adjusted odds ratio was 0.46 (95% CI 0.36 to 0.61).